Yoshitsugu Mitani

3.7k total citations
57 papers, 2.7k citations indexed

About

Yoshitsugu Mitani is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Yoshitsugu Mitani has authored 57 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 25 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Yoshitsugu Mitani's work include Salivary Gland Tumors Diagnosis and Treatment (30 papers), Ear and Head Tumors (13 papers) and Oral and Maxillofacial Pathology (12 papers). Yoshitsugu Mitani is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (30 papers), Ear and Head Tumors (13 papers) and Oral and Maxillofacial Pathology (12 papers). Yoshitsugu Mitani collaborates with scholars based in United States, Japan and Brazil. Yoshitsugu Mitani's co-authors include Naohide Oue, Wataru Yasui, Adel K. El‐Naggar, Hirofumi Nakayama, Phyu P. Aung, Kazuhiro Yoshida, Randal S. Weber, Pulivarthi H. Rao, Carlos Caulı́n and Shunji Matsumura and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Yoshitsugu Mitani

56 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshitsugu Mitani United States 27 1.3k 1.2k 1.2k 458 420 57 2.7k
Renê Gerhard Brazil 21 385 0.3× 985 0.8× 615 0.5× 205 0.4× 365 0.9× 41 1.8k
Patrick W. Heiser United States 13 664 0.5× 873 0.7× 2.0k 1.7× 177 0.4× 325 0.8× 32 2.8k
Hiroyuki Hamakawa Japan 32 476 0.4× 1.4k 1.2× 1.3k 1.1× 189 0.4× 542 1.3× 145 3.0k
Hsuan-Ying Huang Taiwan 30 429 0.3× 700 0.6× 1.2k 1.0× 274 0.6× 434 1.0× 55 2.4k
Kanya Honoki Japan 24 246 0.2× 494 0.4× 1.1k 0.9× 114 0.2× 284 0.7× 150 2.1k
Masayuki Koizumi Japan 25 849 0.7× 1.1k 1.0× 1.6k 1.4× 147 0.3× 406 1.0× 53 3.0k
Motonobu Osada Japan 28 349 0.3× 1.4k 1.2× 2.0k 1.7× 239 0.5× 389 0.9× 46 2.8k
Marcello Guarino Italy 10 185 0.1× 718 0.6× 908 0.8× 157 0.3× 329 0.8× 18 1.8k
Serk In Park United States 27 178 0.1× 1.1k 0.9× 1.2k 1.0× 135 0.3× 472 1.1× 57 2.3k
Jia-Lin Lee South Korea 21 335 0.3× 892 0.8× 919 0.8× 122 0.3× 344 0.8× 50 2.0k

Countries citing papers authored by Yoshitsugu Mitani

Since Specialization
Citations

This map shows the geographic impact of Yoshitsugu Mitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitsugu Mitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitsugu Mitani more than expected).

Fields of papers citing papers by Yoshitsugu Mitani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitsugu Mitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitsugu Mitani. The network helps show where Yoshitsugu Mitani may publish in the future.

Co-authorship network of co-authors of Yoshitsugu Mitani

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitsugu Mitani. A scholar is included among the top collaborators of Yoshitsugu Mitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitsugu Mitani. Yoshitsugu Mitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sousa, Luana Guimarães de, et al.. (2025). Clinical Outcomes With Notch Inhibitors in Notch‐Activated Recurrent/Metastatic Adenoid Cystic Carcinoma. Cancer Medicine. 14(5). e70663–e70663.
2.
Mitani, Yoshitsugu, Luana Guimarães de Sousa, Mario L. Marques‐Piubelli, et al.. (2023). Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma–Specific Prognostic Relevance. Modern Pathology. 37(1). 100371–100371. 3 indexed citations
3.
Sousa, Luana Guimarães de, Daniel J. McGrail, Felippe Lazar Neto, et al.. (2023). Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors. Clinical Cancer Research. 29(16). 3162–3171. 12 indexed citations
4.
Persson, Marta, Mattias K. Andersson, P. Sahlin, et al.. (2023). Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkers. The Journal of Pathology. 261(3). 256–268. 8 indexed citations
5.
Ferrarotto, Renata, Luana Guimarães de Sousa, Lei Feng, et al.. (2023). Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma. Journal of Clinical Oncology. 41(15). 2843–2851. 23 indexed citations
6.
Karpinets, Tatiana V., Yoshitsugu Mitani, Bin Liu, et al.. (2021). Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations. Clinical Cancer Research. 27(14). 3960–3969. 21 indexed citations
7.
Ferrarotto, Renata, Yoshitsugu Mitani, Daniel J. McGrail, et al.. (2020). Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets. Clinical Cancer Research. 27(3). 852–864. 87 indexed citations
8.
Mitani, Yoshitsugu, Sue-Hwa Lin, Kristen B. Pytynia, Renata Ferrarotto, & Adel K. El‐Naggar. (2019). Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma. Clinical Cancer Research. 26(5). 1175–1184. 8 indexed citations
9.
Saintigny, Pierre, Yoshitsugu Mitani, Kristen B. Pytynia, et al.. (2018). Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Cancer. 124(18). 3693–3705. 24 indexed citations
10.
Mitani, Yoshitsugu, Bin Liu, Pulivarthi H. Rao, et al.. (2015). Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clinical Cancer Research. 22(3). 725–733. 154 indexed citations
11.
Mitani, Yoshitsugu, Pulivarthi H. Rao, Sankar N. Maity, et al.. (2014). Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications. Clinical Cancer Research. 20(24). 6570–6581. 56 indexed citations
12.
Zhang, Li, Yoshitsugu Mitani, Carlos Caulı́n, et al.. (2013). Detailed Genome-Wide SNP Analysis of Major Salivary Carcinomas Localizes Subtype-Specific Chromosome Sites and Oncogenes of Potential Clinical Significance. American Journal Of Pathology. 182(6). 2048–2057. 17 indexed citations
13.
Mitani, Yoshitsugu, Pulivarthi H. Rao, P. Andrew Futreal, et al.. (2011). Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYBNFIB Chimeric Fusion, MYB Expression, and Clinical Outcome. Clinical Cancer Research. 17(22). 7003–7014. 116 indexed citations
14.
Mitani, Yoshitsugu, Jie Li, Randal S. Weber, et al.. (2011). Expression and Regulation of the ΔN and TAp63 Isoforms in Salivary Gland Tumorigenesis. American Journal Of Pathology. 179(1). 391–399. 15 indexed citations
15.
Mitani, Yoshitsugu, Jie Li, Pulivarthi H. Rao, et al.. (2010). Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance. Clinical Cancer Research. 16(19). 4722–4731. 219 indexed citations
16.
Oue, Naohide, Yoshitsugu Mitani, Phyu P. Aung, et al.. (2005). Expression and localization of Reg IV in human neoplastic and non‐neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. The Journal of Pathology. 207(2). 185–198. 103 indexed citations
17.
Oue, Naohide, Yoichi Hamai, Yoshitsugu Mitani, et al.. (2004). Gene Expression Profile of Gastric Carcinoma. Cancer Research. 64(7). 2397–2405. 234 indexed citations
18.
Hamai, Yoichi, Naohide Oue, Yoshitsugu Mitani, et al.. (2004). DNA hypermethylation and histone hypoacetylation of the HLTF gene is associated with reduced expression in gastric carcinoma. Cancer Research. 64. 962–962. 7 indexed citations
19.
Oshimo, Yasuhiro, Naohide Oue, Yoshitsugu Mitani, et al.. (2004). Frequent Loss of <i>RUNX3</i> Expression by Promoter Hypermethylation in Gastric Carcinoma. Pathobiology. 71(3). 137–143. 60 indexed citations
20.
Mitani, Yoshitsugu, Shintaro Takaki, Satoru Yamaguchi, et al.. (1956). Development of cervical cancer in surgical cases; surgical pathology of cervical cancer.. PubMed. 3(4). 324–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026